Free Cancer Report

Book Appointment with Dr Rajesh Krishna in Dakshina Kannada

Dr Rajesh Krishna

Hemato Oncologist

6 Years Exp. Dakshina Kannada

Hematological Cancer

Yenepoya Specialty Hospital, Mangalore

6 years of experience

MBBS, MD (General Physician) MRCP (Physician), PRCPath (Pathologist) Р Royal College UK

Dakshina Kannada

500 / consultation

About Dr Rajesh Krishna:

Dr Rajesh Krishna has obtained a Bachelor's degree in Medicine from Dr MGR Medical University, Chennai in 1999 and pursued MD (General Medicine) from the same prestigious institution in 2004. Further, Dr Rajesh attained MRCP (Physicians) in 2006 and FRCPATH (Pathologists) in 2013 from Royal College, United Kingdom. In 2013, he has completed a certificate training in Haematology(PGMETB) from UK. Dr Rajesh Krishna has 6 years of experience in the field of General Medicine and 5 years as specialist in Haematology, Haemato-Oncology and bone marrow transplant with University Hospital, Leisester in the United Kingdom.

Education:

Dr. Rajesh Krishna has obtained a Bachelor's degree in Medicine from Dr MGR Medical University, Chennai in 1999 and pursued MD (General Medicine) from the same prestigious institution in 2004. Further, Dr Rajesh attained MRCP (Physicians) in 2006 and FRCPATH (Pathologists) in 2013 from Royal College, United Kingdom. In 2013, he has completed a certificate training in Haematology(PGMETB) from UK.

Experience:

Dr Rajesh Krishna has 6 years of experience in the field of General Medicine and 5 years as specialist in Haematology, Haemato-oncology and bone marrow transplant with University Hospital, Leisester in the United Kingdom.

Memberships:

British Society of Haematology Fellow of Royal college of Pathologists of UK Indian society of Haematology and blood transfusion (ISHBT) blood transfusion committee Yenepoya Medical College Hospital Mangalore.

Areas of interest:

Blood Cancer, Bone Sarcomas.

Research publications:

Neutrophil engraftment kinetic relationship to timing of Granulocyte Colony Stimulating Factor (G-CSF) in melphalanconditioned autologous stem cell transplant for multiple myeloma patient cohorts from three United Kingdom centres. Rajesh Krishna, Hulegar A Abhishekh, Rachel Brown, Dara Qadir, Vanessa Ellis, Christopher Ardern, Andy Drake, Ann-Marie Sjursen, Jecko Thachil, Muhammed Saif, Fiona Dignan, Fenella Willis, Adrian Bloor, Mickey Koh, Eleni Tholouli, Matthias Klammer, Jim Cavet . British Journal of Haematology(2015), 169, (Suppl. 1), 95 Clinical Trials: A survey of recruitment figures, screening failures and interventions used to increase recruitment over 4 year period in a teaching hospital. E Peat, V Conroy, T Hamrang, C Lobetti, M Saif, F Dignan, E Tholouli, R Krishna. British Journal of Haematology (2015), 169, (Suppl. 1), 97 Bortezomib vial sharing in multiple myeloma (MM) treatment: What is needed for this innovation to succeed? S Sachedina 1 , R Krishna 1 , M Karolia 2 , C Clarke 2 M Watson 2 , D Dhillon 2 , L Barton 1 , M Garg 1.British Journal of Haematology(2016), 173, (Suppl. 1), 92 Avoiding a sticky end: The importance of considering cryoglobulins and cryofibrinogens MP Player, R Krishna, R Gooding, L Barton, G Asagba, M Garg .British Journal of Haematology(2016), 173, (Suppl. 1), 106 Absolute differential between urinary protein creatinine ratio (PCR) and albumin creatinine ratio(ACR): An early warning indicator for multiple myeloma S Sachedina 1 , M Joffe 1 , R Krishna 1 , P Patel 2 , G Asagba 1 , L Barton1, M Garg1..British Journal of Haematology(2016), 173, (Suppl. 1), 5Р178 Clinical profile of long responders (>36 months)to lenalidomide based therapy in multiple myeloma in a single centre M Joffe 1, S Halasag1 , A Nicholds 1 , C Clarke 2 , C Morrow 1 , G Asagba 1, L Barton , M Garg 1, R Krishna 1 1Haematology;2 Pharmacy, University Hospitals of Leicester,Leicester, United Kingdom . British Journal of Haematology(2017), 176, (Suppl. 1), 84

Specialisation

Blood Cancer, Bone Sarcomas.